News about "Biologics License Application (BLA) "

AbbVie Expands US Biologics and API Manufacturing Capacity, Seeks FDA Approval for Rare Blood Cancer Therapy

AbbVie Expands US Biologics and API Manufacturing Capacity, Seeks FDA Approval for Rare Blood Cancer Therapy

AbbVie has begun a USD 70 million expansion of its AbbVie Bioresearch Center (ABC) in Worcester, Massachusetts, and broken ground on a new North Chicago Active Pharmaceutical Ingredient (API) manufacturing facility.

Biologics License Application (BLA) | 01/10/2025 | By Dineshwori


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members